Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
February 26, 2024 - Page 6 of 7 - The Dermatology Digest
Subscribe
Search

Day: February 26, 2024

HS Pipeline Watch: MoonLake Immunotherapeutics’ Sonelokimab Heads to Phase 3

The U.S. Food and Drug Administration (FDA) and E.U. European Medicines Agency (EMA) have greenlighted MoonLake Immunotherapeutics’ Phase 3 Program for the nanobody sonelokimab (SLK) in hidradenitis suppurativa (HS). Sonelokimab is a novel investigational nanobody for the treatment of inflammatory disease. Sonelokimab inhibits IL-17A and IL-17F by inhibiting the IL-17A/A, IL-17A/F, and IL-17F/F dimers that drive inflammation. Sonelokimab is […]